Recently Professor Vanessa Raymont, Director of Research and Development at Oxford Health NHS Foundation Trust (OHFT), spoke to journalists from Sky News and The Times about the READ-OUT dementia study. READ-OUT, a country-wide trial aiming to revolutionise how dementia is diagnosed using blood ... Read More
News Posts
New study for Treatment-Resistant Depression launches at Oxford Health Clinical Research Facility
Recently, the NIHR Oxford Health Clinical Research Facility (OH CRF) has begun researching a new potential drug treatment for Treatment-Resistant Depression. A significant number of people with depression are not helped by at least two antidepressant medications. This is known as ... Read More
Spotlight on Oxford Health Clinical Research Facility
Recently, Oxford Academic Health Partners (OAHP) published a case study focusing on OH CRF's growing and diverse portfolio of studies and highly skilled staff, how we work across the National and Oxford research landscape and what our vision is for the future. The case study includes input and ... Read More
Oxford Health Director of Research and Development discusses READ-OUT with BBC South
Recently, Oxford Health NHS Foundation Trust (OHFT) Director of Research and Development, Professor Vanessa Raymont featured on the BBC discussing the new READ-OUT dementia study, which opens at the Trust this month. The READ-OUT study is a national multi-site study in collaboration ... Read More
What are the best treatments for movement disorder in people with schizophrenia or mood disorders?
Professor Andrea Cipriani, Professor of Psychiatry at the University of Oxford and Director of the NIHR Oxford Health Clinical Research Facility (OH CRF), has led on a study which analysed treatments for tardive dyskinesia (TD) in people with schizophrenia or mood disorders. TD is a ... Read More
Society of Digital Psychiatry’s First Annual Symposium
Dr. Katherine Smith, Clinical Lead for the Oxford Health Clinical Research Facility (OH CRF), recently gave a talk at the first annual symposium of the Society of Digital Psychiatry. The talk is titled "Challenges/Solutions in Digital Mental Health for Schizophrenia", and you can watch it below. ... Read More
VIP visit for Oxford Health Clinical Research Facility
Recently Layla Moran, Liberal Democrat MP for Oxford West and Abingdon and Chair of the Health and Social Care Select Committee visited the Oxford Health Clinical Research Facility (OH CRF). The MP and her team were onsite at Warneford Hospital discussing plans for the Warneford Park ... Read More
Alzheimer’s Disease Biomarker Pilot Project launched at Oxford Health Clinical Research Facility
Dementia is widely recognised as one of the largest global public health challenges and the most common cause of dementia is Alzheimer’s Disease (AD). In 2022, dementia and Alzheimer's disease was the leading cause of death in the UK and with approximately 33% of the UK population aged fifty or ... Read More
Research colleagues host coffee afternoon to promote research opportunities
Recently, research colleagues came together to host a Research Coffee Afternoon at Buckinghamshire New University in Aylesbury. The aim of the event was to engage the university’s students, staff and visiting members of the public in health care research, informally over a cup of coffee and ... Read More
60 seconds with…. Oxford Health Clinical Research Facility (OH CRF) Team Lead Debbie Moll
Debbie Moll, who recently started as the CRF Team Lead speaks about her career in research. Debbie previously worked as a researcher in the Oxford Health NHS Foundation Trust’s Memory and Cognition Research Delivery Team and also worked part-time as OH CRF’s Patient and Public Involvement (PPI) ... Read More
NIHR BRC and CRF Inclusion Conference
Birmingham Biomedical Research Centre (BBRC) and Clinical Research Facility (BCRF) played host to the first Biomedical Research Centre (BRC) and Clinical Research Facility (CRF) Inclusion Conference at “The Exchange” in Birmingham on 17 October. The event provided BRC and ... Read More
New study for Treatment-Resistant Depression launches at Oxford Health Clinical Research Facility
Recently, the NIHR Oxford Health Clinical Research Facility (OH CRF) has begun researching a new potential drug treatment for Treatment-Resistant Depression (TRD). A significant number of people with depression are not helped by at least two antidepressant medications. This is known as ... Read More
Colleagues present at International Mental Health Nursing Research Conference
Recently, colleagues from the Oxford Health Clinical Research Facility (OH CRF) and Oxford Health Research & Development team attended the 29th International Mental Health Nursing Research Conference, held at St Catherine’s College, Oxford. The aim of the event was to share knowledge and best ... Read More
Which drugs are the most effective for acute migraines?
Triptans, a drug usually offered as an alternative to painkillers, have been found to be the most effective medicine for adults who experience acute migraines. Findings of a study, which recruited over 89,000 participants, compared 17 oral medications commonly used to treat migraines were ... Read More
Oxford Health R&D staff talk about studies at Dementia Oxfordshire event
Research staff at Oxford Health recently attended the Autumn Information Fayre at the Windmill Centre in Deddington to provide information on dementia and opportunities to take part in dementia research. Clinical Research Facilitators Zoe Collett and Ariana Cortez from the Oxford Health Memory ... Read More
Oxford Health Clinical Research Facility (OH CRF) to present at mental health research conference
Colleagues from Oxford Health Research & Development team are attending the International Mental Health Nursing Research Conference, a knowledge sharing event dedicated to research in mental health nursing. Debbie Moll, Research Speech and Language Therapist in the Memory and Cognition ... Read More
New drug to treat patients in the early stages of Alzheimer’s
This week, a product licence for the medicine lecanemab (Leqembi) was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adult patients in the early stages of Alzheimer’s disease. The medication has shown some evidence of efficacy in slowing progression of the ... Read More
Oxford Health R&D team represented at Dementia Oxfordshire event
Oxford Health research staff will be attending the Autumn Information Fayre on Wednesday 4 September at the Windmill Centre in Deddington to provide information on dementia research taking place in Oxford. The information drop-in event runs from 10am to 3pm and is hosted ... Read More
Oxford Health’s Clinical Research Facility attend the 2024 UKCRF Network conference
Staff from Oxford Health’s Clinical Research Facility (CRF) spent two engaging days at the UK CRF Network conference in Leicester from 4-5 July 2024. Although the event took place during the election, staff were reminded in advance to organise postal votes, and attendance was not affected. The ... Read More
Oxford Health Clinical Research Facility joins Oxford Pride 2024 celebrations
What is Pride and why did we attend? The Oxford Pride 2024 celebrated the LGBTQIA+ community and its 21st anniversary of the event with the theme “One City – One Pride: Embrace Your Rainbow.” The day brought Oxford’s diverse communities together for an annual parade through the ... Read More